Answers are grounded in this paper and cite their sources.
The siderophore-cephalosporin cefiderocol (FDC) presents a promising treatment option for carbapenem-resistant (CR)
No takes yet. Share an insight, caveat, or question.
Egge et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: